 |
Delegates
attending this course will benefit from an introductory overview
of the terminology and classification of cancer and principle issues
in its treatment. Commonly available anti-cancer drugs will be reviewed,
particularly in relation to mode of action, dose intensity and chemotherapy
regimes. This will lead on to a detailed study of the range of side
effects commonly and uncommonly experienced by people with cancer
undergoing chemotherapy treatment. Quality of life issues in terms
of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumour
types; breast, lung, upper gastrointestinal (GI), colorectal, ovarian
and malignant melanoma and renal cancer. Each session will be presented
by clinicians active in these areas and will focus on overall patient
presentation and management, cancer diagnosis and staging. Following
these sessions, our experts will lead delegates in interactive group
discussions on the key issues relating to effective management of
each tumour type.
The limitations of cytotoxic drugs currently available are well
known. With this in mind, the course includes in-depth discussion
on new drug development and identification of new pharmacological
targets of particular interest and value. Clinical trial design
issues will also be included.
CPD accreditation:
Healthcare’s
programmes are approved by the Faculty of Pharmaceutical Medicine
for CPD accreditation. Details can be supplied on request.
Topics to be covered include:
Cancer: Terminology and classification
Introduction to anti-cancer drugs
-
Side-effects of chemotherapy and radiotherapy
New developments in cancer therapy
-
Introduction to the major tumour types including;:
breast, lung, colorectal, malignant melanoma, ovarian, GI and
renal cancer
Clinical trial issues in oncology
Chairmen
Professor Jim Cassidy
University of Glasgow, UK
Professor Jaap Verweij
Erasmus Medical Center
Rotterdam, The Netherlands
Top
|
|
|
Why not also buy a copy of our
PharmaEssentials
Guide to oncology
109 pages (PDF)
More information >>
|
|
Who should attend? |
|
Healthcare’s courses are designed
for both medical and non-medical staff within the pharmaceutical
industry. This course is suitable for clinical research, medical
information, regulatory affairs, biometrics and strategic
marketing personnel.
|
| |
|
Fees |
|
The registration fee is £1,975 plus
VAT/TAXES. This includes lunch and refreshments throughout
the day. Accommodation costs are not included.
Delegates can register on-line or by completing the booking
form and returning it together with the appropriate payment
to Healthcare Education Services Limited.
Please retain a copy of the booking form for your records.
A reduced academic/NHS fee is available—please contact
Healthcare for details. |
| |
|
Venue / Accommodation |
|
Details of the venue will be supplied on
registration.
Accommodation costs are not included in the course fee. However,
Healthcare has organised a special bed and breakfast
rate at the venue for delegates who require overnight accommodation—details
of how to book will be provided with registration documentation. |
| |
|
